Skip to main content
. 2024 Oct 4;10(19):e38936. doi: 10.1016/j.heliyon.2024.e38936

Fig. 7.

Fig. 7

A schematic abstract illustrating RosA's effects on both inhibiting catabolic factors and promoting ECM synthesis through the inhibition of the NF-κB pathway.